DERMOTIC (fluocinolone acetonide) by Eurofarma Laboratórios is corticosteroid hormone receptor agonists [moa]. First approved in 1988.
Drug data last refreshed 4h ago · AI intelligence enriched 1w ago
DERMOTIC is a fluocinolone acetonide otic oil/drops formulation approved in 1988 for ear inflammation and related dermatological conditions of the external auditory canal. It is a corticosteroid hormone receptor agonist that reduces inflammation and pruritus in otologic indications. The product is administered topically via drops directly into the affected ear.
With LOE approaching and modest Part D spending, the brand team is likely in defensive/transition mode; expect smaller team size focused on retention rather than expansion.
Corticosteroid Hormone Receptor Agonists
Corticosteroid
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis
Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant
Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant
Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study
Worked on DERMOTIC at Eurofarma Laboratórios? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moDERMOTIC offers limited career growth opportunity given its LOE-approaching lifecycle and minimal linked job postings. Roles on this team are primarily defensive, focused on managing market decline and protecting existing market share rather than launching or growing a product.